Cite

HARVARD Citation

    von Spreckelsen, N. et al. (2021). Targeting Glioblastoma Using a Novel Peptide Specific to a Deglycosylated Isoform of Brevican. Advanced therapeutics. 4 (4), p. n/a. [Online]. 
  
Back to record